Title:
TREATMENT OF IRRITABLE BOWEL SYNDROME AND NONULCER DYSPEPSIA WITH SUBSTITUTED 2,3-BENZODIAZEPINES
Document Type and Number:
WIPO Patent Application WO2004050616
Kind Code:
A3
Abstract:
Compounds according to Formula: (I) wherein R<1>, R<2>, R<3>, R<4>, R <5 >and R <6 >are as defined herein, administered for irritable bowel syndrome and nonulcer dyspepsia.
Inventors:
HARRIS HERBERT W (US)
KUCHARIK ROBERT F (US)
KUCHARIK ROBERT F (US)
Application Number:
PCT/US2003/038637
Publication Date:
September 10, 2004
Filing Date:
December 03, 2003
Export Citation:
Assignee:
VELA PHARMACEUTICALS INC (US)
HARRIS HERBERT W (US)
KUCHARIK ROBERT F (US)
HARRIS HERBERT W (US)
KUCHARIK ROBERT F (US)
International Classes:
A61K31/551; (IPC1-7): A61K31/551
Other References:
OSIPENKO ET AL: "Role of Grandaxin in the treatment of functional gastrointest inal diseases", TERAPEVTICHESKII ARKHIV, vol. 72, no. 10, 2000, pages 23 - 27, XP002978737
See also references of EP 1567162A4
See also references of EP 1567162A4
Download PDF:
Previous Patent: METHOD OF INCREASING NEUTROPHIL PRODUCTION USING 2,3-BENZODIAZEPINES
Next Patent: CRYSTALLINE FORM F OF ATORVASTATIN HEMI-CALCIUM SALT
Next Patent: CRYSTALLINE FORM F OF ATORVASTATIN HEMI-CALCIUM SALT